Chief Executive Officer and Board Member @ (April 2021 - March 2024)
Government Affairs Committee Member @ (June 2019 - June 2021)
Chief Operating Officer @ (September 2017 - April 2020)
Chief Operating Officer @ Momenta Pharmaceuticals (acquired by J&J for $6.5B) (December 2015 - May 2017)
SVP, Strategy and Emerging Businesses @ (July 2014 - July 2015)
Head of Tysabri Franchise @ (April 2012 - June 2014)
Chief of Staff to CEO @ (October 2010 - April 2012)
President, Syntonix Pharmaceuticals; General Manager, Hemophilia Business Unit @ (October 2007 - October 2010)
VP, Global Operations @ (January 2005 - March 2008)
Product Development Committee Lead; Operations; Product Planning; Finance @ (August 1999 - December 2004)
Market Development Intern @ (January 1998 - January 1998)
Associate, Business Analyst @ A.T. Kearney (management consulting) (January 1993 - January 1997)
Matt Ottmer Education
Northwestern University - Kellogg School of Management
MBA (Finance, Marketing, Health Care)
1997-1999
University of Michigan
B.A. (Political Science, Pre-Med)
1989-1993
Matt Ottmer Summary
Matt Ottmer, based in Boston, MA, US, is currently a Chief Operating Officer at Ukko. Matt Ottmer brings experience from previous roles at Independent Consultant, Kisbee Therapeutics, American Society of Gene & Cell Therapy and Voyager Therapeutics, Inc.. Matt Ottmer holds a 1997 - 1999 MBA in Finance, Marketing, Health Care @ Northwestern University - Kellogg School of Management. Matt Ottmer has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Matt Ottmer?
Find contact details for 700 million professionals.